The EU Court of Justice, in its judgment given in Case C-291/22 P, annulled the European Medicines’s decision denying marketing authorization for a drug, finding that the evaluation process was vitiated by the presence within the Committee for Medicinal Products for Human Use of an expert who was in a situation of conflict of interest.
After three days of extensive final debate the EU Parliament, Council and Commission finally announced provisional agreement on the EU AI Act, the bloc’s landmark legislation regulating development and use of AI in the European Union. It is one of the world’s first comprehensive attempts to regulate the use of AI.
The EU AI Act awaits formal adoption by both Parliament and Council before it will become EU law.
Baker McKenzie’s Sanctions Blog published the alert titled Focus by US, EU, UK and other authorities on third countries and anti-circumvention of Russia sanctions on 8 March 2023. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.
On 28 November 2022, the EU institutions formally adopted a Regulation on foreign subsidies distorting the internal market. The new rules will have a major impact on M&A transactions and will significantly increase the administrative burden facing many EU and non-EU companies doing business in Europe. The Regulation is part of a broader effort to protect the EU’s geopolitical “open strategic autonomy”. It aims to level the playing field by allowing the European Commission to intervene where foreign subsidies granted directly or indirectly by third countries threaten to distort the EU internal market.